The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Animal models of Multiple Sclerosis
Open accessAbstract
Multiple Sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS) which involves a complex interaction between immune system and neural cells. Animal modeling has been critical for addressing MS pathogenesis. The three most characterized animal models of MS are (1) the experimental autoimmune/allergic encephalomyelitis (EAE); (2) the virally-induced chronic demyelinating disease, known as Theiler׳s murine encephalomyelitis virus (TMEV) infection and (3) the toxin-induced demyelination. All these models, in a complementary way, have allowed to reach a good knowledge of the pathogenesis of MS. Specifically, EAE is the model which better reflects the autoimmune pathogenesis of MS and is extremely useful to study potential experimental treatments. Furthermore, both TMEV and toxin-induced demyelination models are suitable for characterizing the role of the axonal injury/repair and the remyelination process in MS. In conclusion, animal models, despite their limitations, remain the most useful instrument for implementing the study of MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, C. H., O'Connor, P. W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., Lublin, F. D., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,386
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759
Multiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740
Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin
Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., & Karin, N. (1992) · Nature · doi:10.1038/356063a0 · Cited by 1,737
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
Environmental risk factors for multiple sclerosis. Part I: The role of infection
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21117 · Cited by 1,042
Autoimmune T cell responses in the central nervous system
Goverman, J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2550 · Cited by 1,030
Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D., & Fathman, C. G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.5 · Cited by 989
Matsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984
Hartung, H.-P., Gonsette, R., Konig, N., Kwiecinski, H., Guseo, A., Morrissey, S. P., Krapf, H., & Zwingers, T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)12023-x · Cited by 946
Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G., & Janeway, C. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.57 · Cited by 835
Bettelli, E., Pagany, M., Weiner, H. L., Linington, C., Sobel, R. A., & Kuchroo, V. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021603 · Cited by 825
Bielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., Gran, B., Eaton, J., Antel, J., Frank, J. A., et al. (2000) · Nature Medicine · doi:10.1038/80516 · Cited by 823
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T. R., Bäckström, B. T., Sobel, R. A., Wucherpfennig, K. W., Strom, T. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1564 · Cited by 811
International MS Genetics Consortium, De Jager, P. L., Jia, X., Wang, J., de Bakker, P. I. W., Ottoboni, L., Aggarwal, N. T., Piccio, L., Raychaudhuri, S., Tran, D., et al. (2009) · Nature Genetics · doi:10.1038/ng.401 · Cited by 800
Jäger, A., Dardalhon, V., Sobel, R. A., Bettelli, E., & Kuchroo, V. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901906 · Cited by 783
Kohm, A. P., Carpentier, P. A., Anger, H. A., & Miller, S. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4712 · Cited by 782
Panitch, H. S., Hirsch, R. L., Schindler, J., & Johnson, K. P. (1987) · Neurology · doi:10.1212/wnl.37.7.1097 · Cited by 751
Experimental Autoimmune Encephalomyelitis Induction in Genetically B Cell–deficient Mice
Wolf, S. D., Dittel, B. N., Hardardottir, F., & Janeway, C. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2271 · Cited by 699
OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS
Rivers, T. M., Sprunt, D. H., & Berry, G. P. (1933) · Journal of Experimental Medicine · doi:10.1084/jem.58.1.39 · Cited by 643
Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells
Stromnes, I. M., Cerretti, L. M., Liggitt, D., Harris, R. A., & Goverman, J. M. (2008) · Nature Medicine · doi:10.1038/nm1715 · Cited by 630
Mendel, I., de Rosbo, N. K., & Ben‐Nun, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250723 · Cited by 601
Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V., & Segal, B. M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080159 · Cited by 579
Preferential recruitment of interferon‐γ–expressing T H 17 cells in multiple sclerosis
Kebir, H., Ifergan, I., Alvarez, J. I., Bernard, M., Poirier, J., Arbour, N., Duquette, P., & Prat, A. (2009) · Annals of Neurology · doi:10.1002/ana.21748 · Cited by 551
Epstein-Barr Virus Antibodies and Risk of Multiple Sclerosis: A Prospective Study
Ascherio, A., Munger, K. L., Lennette, E. T., Spiegelman, D., Hernán, M. A., Olek, M. J., Hankinson, S. E., & Hunter, D. J. (2001) · JAMA · doi:10.1001/jama.286.24.3083 · Cited by 549
T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination
Zamvil, S., Nelson, P., Trotter, J., Mitchell, D., Knobler, R., Fritz, R., & Steinman, L. (1985) · Nature · doi:10.1038/317355a0 · Cited by 530
Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune disease
Dominguez-Villar, M., Baecher-Allan, C. M., & Hafler, D. A. (2011) · Nature Medicine · doi:10.1038/nm.2389 · Cited by 526
McRae, B. L., Vanderlugt, C. L., Dal Canto, M. C., & Miller, S. D. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.1.75 · Cited by 518
Kappos, L., Comi, G., Panitch, H., Oger, J., Antel, J., Conlon, P., Steinman, L., Comi, G., Kappos, L., Oger, J., et al. (2000) · Nature Medicine · doi:10.1038/80525 · Cited by 512
Coles, A. J., Cox, A., Page, E., Jones, J., Trip, S. A., Deans, J., Seaman, S., Miller, D. H., Hale, G., Waldmann, H., et al. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0934-5 · Cited by 506
Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis
Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H., & Kuchroo, V. K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031819 · Cited by 488
Steinman, L., & Zamvil, S. S. (2006) · Annals of Neurology · doi:10.1002/ana.20913 · Cited by 479
Haas, J., Hug, A., Viehöver, A., Fritzsching, B., Falk, C. S., Filser, A., Vetter, T., Milkova, L., Korporal, M., Fritz, B., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526065 · Cited by 449
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis
Hofstetter, H. H., Ibrahim, S. M., Koczan, D., Kruse, N., Weishaupt, A., Toyka, K. V., & Gold, R. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.11.002 · Cited by 423
McFarlin, D. E., & McFarland, H. F. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211043071905 · Cited by 416
Kabat, E. A., Wolf, A., & Bezer, A. E. (1947) · Journal of Experimental Medicine · doi:10.1084/jem.85.1.117 · Cited by 403
Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions
Hauser, S. L., Bhan, A. K., Gilles, F., Kemp, M., Kerr, C., & Weiner, H. L. (1986) · Annals of Neurology · doi:10.1002/ana.410190610 · Cited by 399
Rangachari, M., Zhu, C., Sakuishi, K., Xiao, S., Karman, J., Chen, A., Angin, M., Wakeham, A., Greenfield, E. A., Sobel, R. A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2871 · Cited by 394
Neurofascin as a novel target for autoantibody-mediated axonal injury
Mathey, E. K., Derfuss, T., Storch, M. K., Williams, K. R., Hales, K., Woolley, D. R., Al-Hayani, A., Davies, S. N., Rasband, M. N., Olsson, T., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071053 · Cited by 390
Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12
Becher, B., Durell, B. G., & Noelle, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15751 · Cited by 386
Sensitization to Horse Serum by Means of Adjuvants
Freund, J., & McDermott, K. (1942) · Experimental Biology and Medicine · doi:10.3181/00379727-49-13625 · Cited by 368
Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice.
Tuohy, V. K., Lu, Z., Sobel, R. A., Laursen, R. A., & Lees, M. B. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.5.1523 · Cited by 367
Zhang, X. (2004) · International Immunology · doi:10.1093/intimm/dxh029 · Cited by 363
Sanna, V., Giacomo, A. D., Cava, A. L., Lechler, R. I., Fontana, S., Zappacosta, S., & Matarese, G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16721 · Cited by 362
Self-citationLess Mortality but More Relapses in Experimental Allergic Encephalomyelitis in CD8 -/- Mice
Koh, D.-R., Fung-Leung, W.-P., Ho, A., Gray, D., Acha-Orbea, H., & Mak, T.-W. (1992) · Science · doi:10.1126/science.256.5060.1210 · Cited by 352
Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12
Becher, B., Durell, B. G., & Noelle, R. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215751 · Cited by 346
Anti-α4 integrin therapy for multiple sclerosis: Mechanisms and rationale
Rice, G. P. A., Hartung, H.-P., & Calabresi, P. A. (2005) · Neurology · doi:10.1212/01.wnl.0000158329.30470.d0 · Cited by 305
Matarese, G., Carrieri, P. B., La Cava, A., Perna, F., Sanna, V., De Rosa, V., Aufiero, D., Fontana, S., & Zappacosta, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408995102 · Cited by 302
Self-citationLyons, J.-A., San, M., Happ, M. P., & Cross, A. H. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3432::aid-immu3432>3.0.co;2-2 · Cited by 292
Shields, S. A., Gilson, J. M., Blakemore, W. F., & Franklin, R. J. M. (1999) · Glia · doi:10.1002/(sici)1098-1136(199910)28:1<77::aid-glia9>3.0.co;2-f · Cited by 287
Remyelination in Experimental Models of Toxin-Induced Demyelination
Blakemore, W. F., & Franklin, R. J. M. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-73677-6_8 · Cited by 275
Hall, S. M. (1972) · Journal of Cell Science · doi:10.1242/jcs.10.2.535 · Cited by 274
Aharoni, R., Teitelbaum, D., Sela, M., & Arnon, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10821 · Cited by 274
van Oosten, B. W., Lai, M., Hodgkinson, S., Barkhof, F., Miller, D. H., Moseley, I. F., Thompson, A. J., Rudge, P., McDougall, A., McLeod, J. G., et al. (1997) · Neurology · doi:10.1212/wnl.49.2.351 · Cited by 264
Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis
Sriram, S., & Steiner, I. (2005) · Annals of Neurology · doi:10.1002/ana.20743 · Cited by 264
Hafler, D. A., Slavik, J. M., Anderson, D. E., O'Connor, K. C., De Jager, P., & Baecher‐Allan, C. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00240.x · Cited by 260
Litzenburger, T., Fässler, R., Bauer, J., Lassmann, H., Linington, C., Wekerle, H., & Iglesias, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.169 · Cited by 256
Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients
Jacobsen, M., Cepok, S., Quak, E., Happel, M., Gaber, R., Ziegler, A., Schock, S., Oertel, W. H., Sommer, N., & Hemmer, B. (2002) · Brain · doi:10.1093/brain/awf059 · Cited by 253
McRae, B. L., Kennedy, M. K., Tan, L.-J., Dal Canto, M. C., Picha, K. S., & Miller, S. D. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90016-e · Cited by 241
Epidemiologic contributions to multiple sclerosis: An overview
Kurtzke, J. F. (1980) · Neurology · doi:10.1212/wnl.30.7_part_2.61 · Cited by 236
Peters, A., Lee, Y., & Kuchroo, V. K. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.08.007 · Cited by 231
Regulatory T cells in autoimmune neuroinflammation
Kleinewietfeld, M., & Hafler, D. A. (2014) · Immunological Reviews · doi:10.1111/imr.12169 · Cited by 230
ALLERGIC ENCEPHALOMYELITIS IN MONKEYS IN RESPONSE TO INJECTION OF NORMAL MONKEY NERVOUS TISSUE
Morgan, I. M. (1947) · Journal of Experimental Medicine · doi:10.1084/jem.85.1.131 · Cited by 224
Domingues, H. S., Mues, M., Lassmann, H., Wekerle, H., & Krishnamoorthy, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015531 · Cited by 221
Derfuss, T., Parikh, K., Velhin, S., Braun, M., Mathey, E., Krumbholz, M., Kümpfel, T., Moldenhauer, A., Rader, C., Sonderegger, P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901496106 · Cited by 221
Liu, L., Belkadi, A., Darnall, L., Hu, T., Drescher, C., Cotleur, A. C., Padovani-Claudio, D., He, T., Choi, K., Lane, T. E., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2491 · Cited by 214
Hjelmström, P., Juedes, A. E., Fjell, J., & Ruddle, N. H. (1998) · PubMed · Cited by 214
Animal models of multiple sclerosis—Potentials and limitations
Mix, E., Meyer-Rienecker, H., Hartung, H.-P., & Zettl, U. K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.005 · Cited by 210
Freund, J., Stern, E. R., & Pisani, T. M. (1947) · The Journal of Immunology · doi:10.4049/jimmunol.57.2.179 · Cited by 199
Efficient central nervous system remyelination requires T cells
Bieber, A. J., Kerr, S., & Rodriguez, M. (2003) · Annals of Neurology · doi:10.1002/ana.10578 · Cited by 196
Tompkins, S. M., Padilla, J., Dal Canto, M. C., Ting, J. P.-Y., Van Kaer, L., & Miller, S. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.4173 · Cited by 190
Multiple sclerosis: T-cell receptor expression in distinct brain regions
Junker, A., Ivanidze, J., Malotka, J., Eiglmeier, I., Lassmann, H., Wekerle, H., Meinl, E., Hohlfeld, R., & Dornmair, K. (2007) · Brain · doi:10.1093/brain/awm214 · Cited by 189
Reddy, J., Illes, Z., Zhang, X., Encinas, J., Pyrdol, J., Nicholson, L., Sobel, R. A., Wucherpfennig, K. W., & Kuchroo, V. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404444101 · Cited by 187
Woodroofe, M. N., Bellamy, A. S., Feldmann, M., Davison, A. N., & Cuzner, M. L. (1986) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(86)90100-0 · Cited by 186
Multiple sclerosis: Involvement of interferons in lesion pathogenesis
Traugott, U., & Lebon, P. (1988) · Annals of Neurology · doi:10.1002/ana.410240211 · Cited by 186
Hjelmström, P., Juedes, A. E., Fjell, J., & Ruddle, N. H. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4480 · Cited by 186
Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin
Jeffery, N. D., & Blakemore, W. F. (1995) · Journal of Neurocytology · doi:10.1007/bf01191213 · Cited by 183
IL-12 unmasks latent autoimmune disease in resistant mice.
Segal, B. M., & Shevach, E. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.771 · Cited by 182
Lipton, H. L., Twaddle, G., & Jelachich, M. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2525-2533.1995 · Cited by 180
Olson, J. K., Girvin, A. M., & Miller, S. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.20.9780-9789.2001 · Cited by 178
Integrating risk factors: HLA-DRB1*1501 and Epstein–Barr virus in multiple sclerosis
De Jager, P. L., Simon, K. C., Munger, K. L., Rioux, J. D., Hafler, D. A., & Ascherio, A. (2008) · Neurology · doi:10.1212/01.wnl.0000294325.63006.f8 · Cited by 176
Hu, Y., Ota, N., Peng, I., Refino, C. J., Danilenko, D. M., Caplazi, P., & Ouyang, W. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903614 · Cited by 174
Pathogenic CD8+ T cells in multiple sclerosis
Friese, M. A., & Fugger, L. (2009) · Annals of Neurology · doi:10.1002/ana.21744 · Cited by 171
Oliver, A. R., Lyon, G. M., & Ruddle, N. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.462 · Cited by 171
Ciliary neurotrophic factor: Pharmacokinetics and acute‐phase response in rat
Dittrich, F., Theonen, H., & Sendtner, M. (1994) · Annals of Neurology · doi:10.1002/ana.410350206 · Cited by 169
The genetics of autoimmune diseases: a networked perspective
Baranzini, S. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.09.014 · Cited by 160
Krishnamoorthy, G., Saxena, A., Mars, L. T., Domingues, H. S., Mentele, R., Ben‐Nun, A., Lassmann, H., Dornmair, K., Kurschus, F. C., Liblau, R., et al. (2009) · Nature Medicine · doi:10.1038/nm.1975 · Cited by 155
Ford, M. L., & Evavold, B. D. (2004) · European Journal of Immunology · doi:10.1002/eji.200425660 · Cited by 149
Unraveling the Genetics of Autoimmunity
Zenewicz, L. A., Abraham, C., Flavell, R. A., & Cho, J. H. (2010) · Cell · doi:10.1016/j.cell.2010.03.003 · Cited by 149
Cuprizone [Bis(Cyclohexylidenehydrazide)] is Selectively Toxic for Mature Oligodendrocytes
Bénardais, K., Kotsiari, A., Škuljec, J., Koutsoudaki, P. N., Gudi, V., Singh, V., Vulinović, F., Skripuletz, T., & Stangel, M. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9380-9 · Cited by 148
Berard, J. L., Wolak, K., Fournier, S., & David, S. (2010) · Glia · doi:10.1002/glia.20935 · Cited by 147
Tsunoda, I., & Fujinami, R. S. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9179-x · Cited by 147
Giant Hepatic Mitochondria: Production in Mice Fed with Cuprizone
Suzuki, K. (1969) · Science · doi:10.1126/science.163.3862.81 · Cited by 146
Genetic proof for the transient nature of the Th17 phenotype
Kurschus, F. C., Croxford, A. L., Heinen, A. P., Wörtge, S., Ielo, D., & Waisman, A. (2010) · European Journal of Immunology · doi:10.1002/eji.201040755 · Cited by 141
Rosa, V. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26523 · Cited by 139
The mechanism of action of glatiramer acetate treatment in multiple sclerosis
Racke, M. K., Lovett‐Racke, A. E., & Karandikar, N. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c97e39 · Cited by 134
de Andrés, C., Aristimuño, C., Heras, V. D. L., Martínez-Ginés, M. L., Bartolomé, M., Arroyo, R., Navarro, J., Giménez-Roldán, S., Fernández‐Cruz, E., & Sánchez‐Ramón, S. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.09.012 · Cited by 134
QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2
Encinas, J. A., Wicker, L. S., Peterson, L. B., Mukasa, A., Teuscher, C., Sobel, R. A., Weiner, H. L., Seidman, C. E., Seidman, J. G., & Kuchroo, V. K. (1999) · Nature Genetics · doi:10.1038/5941 · Cited by 131
Whitham, R. H., Bourdette, D. N., Hashim, G. A., Herndon, R. M., Ilg, R. C., Vandenbark, A. A., & Offner, H. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.1.101 · Cited by 130 · cited 3×
“Some of them are myelin constituents, such as neurofascin NF 155 (Mathey et al., 2007) , others are expressed on myelin and axons, such as contactin-2/transient axonal glycoprotein-1 (TAG-1) (Derfuss et al., 2009) and some other are entirely non-myelin antigens, such as the neuronal membrane protein neurofascin NF 186…”
BackgroundRole of macrophages during Theiler's virus infection
Rossi, C. P., Delcroix, M., Huitinga, I., McAllister, A., van Rooijen, N., Claassen, E., & Brahic, M. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3336-3340.1997 · Cited by 128
EXPERIMENTAL DISSEMINATED ENCEPHALOMYELITIS IN WHITE MICE
Olitsky, P. K., & Yager, R. H. (1949) · The Journal of Experimental Medicine · doi:10.1084/jem.90.3.213 · Cited by 128
Murray, P. D., Pavelko, K. D., Leibowitz, J. L., Lin, X., & Rodriguez, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7320-7329.1998 · Cited by 127
Gerety, S. J., Rundell, M. K., Canto, M. C. D., & Miller, S. D. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.919 · Cited by 123
Mestre, L., Docagne, F., Correa, F., Loría, F., Hernangómez, M., Borrell, J. I., & Guaza, C. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.10.015 · Cited by 116
Axonal Injury Heralds Virus-Induced Demyelination
Tsunoda, I., Kuang, L., Libbey, J. E., & Fujinami, R. S. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63922-3 · Cited by 112
Aharoni, R., Herschkovitz, A., Eilam, R., Blumberg-Hazan, M., Sela, M., Brück, W., & Arnon, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804632105 · Cited by 112
Experimental autoimmune encephalomyelitis – achievements and prospective advances
Batoulis, H., Recks, M. S., Addicks, K., & Küerten, S. (2011) · Apmis · doi:10.1111/j.1600-0463.2011.02794.x · Cited by 103
Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen
Munoz, J. J., Bernard, C. C. A., & Mackay, I. R. (1984) · Cellular Immunology · doi:10.1016/0008-8749(84)90228-4 · Cited by 100
IFN-γ Determines Distinct Clinical Outcomes in Autoimmune Encephalomyelitis
Wensky, A. K., Furtado, G. C., Marcondes, M. C. G., Chen, S., Manfra, D. J., Lira, S. A., Zagzag, D., & Lafaille, J. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1416 · Cited by 97
Regulatory T cells fail to suppress CD4+ T‐bet+ T cells in relapsing multiple sclerosis patients
Frisullo, G., Nociti, V., Iorio, R., Patanella, A. K., Caggiula, M., Marti, A., Sancricca, C., Angelucci, F., Massimiliano Mirabella, A., Tonali, P. A., et al. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02963.x · Cited by 96
Suppression of experimental allergic encephalomyelitis by mitoxantrone
Ridge, S. C., Sloboda, A. E., McReynolds, R. A., Levine, S., Oronsky, A. L., & Kerwar, S. S. (1985) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(85)90075-3 · Cited by 94
Morrissey, S., Stodal, H., Zettl, U. K., Simonis, C., Jung, S., Kiefer, R., Lassmann, H., Hartung, H., Haase, A., & Toyka, K. V. (1996) · Brain · doi:10.1093/brain/119.1.239 · Cited by 94
Mars, L. T., Saikali, P., Liblau, R., & Arbour, N. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.006 · Cited by 91
Korporal, M., Haas, J., Balint, B., Fritzsching, B., Schwarz, A., Moeller, S., Fritz, B., Suri‐Payer, E., & Wildemann, B. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1434 · Cited by 90
Experimental models of multiple sclerosis
Pachner, A. R. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328346c226 · Cited by 90
Current Disease-Modifying Therapies in Multiple Sclerosis
Kieseier, B. C., & Hartung, H. (2003) · Seminars in Neurology · doi:10.1055/s-2003-41138 · Cited by 89
Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis
Link, H., Sun, J., Wang, Z., Xu, Z., Löve, A., Fredrikson, S., & Olsson, T. P. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90091-x · Cited by 87
Pathogenesis of multiple sclerosis: A critical reappraisal
Poser, C. M. (1986) · Acta Neuropathologica · doi:10.1007/bf00687954 · Cited by 85
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
Longbrake, E. E., & Racke, M. K. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.9.3.319 · Cited by 79
The use of mouse models to better understand mechanisms of autoimmunity and tolerance
Miyagawa, F., Gutermuth, J., Zhang, H., & Katz, S. I. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.06.007 · Cited by 78
Elain, G., Jeanneau, K., Rutkowska, A., Mir, A. K., & Dev, K. K. (2014) · Glia · doi:10.1002/glia.22637 · Cited by 77
Komoly, S., Jeyasingham, M. D., Pratt, O. E., & Lantos, P. L. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90268-1 · Cited by 73
A Transgenic Model of Central Nervous System Autoimmunity Mediated by CD4+ and CD8+ T and B Cells
Anderson, A. C., Chandwaskar, R., Lee, D. H., Sullivan, J. M., Solomon, A., Rodriguez‐Manzanet, R., Greve, B., Sobel, R. A., & Kuchroo, V. K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102186 · Cited by 68
Abromson‐Leeman, S. R., Bronson, R. T., & Dorf, M. E. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.07.007 · Cited by 65
Fujinami, R. S., Rosenthal, A., Lampert, P. W., Zurbriggen, A., & Yamada, M. (1989) · Journal of Virology · doi:10.1128/jvi.63.5.2081-2087.1989 · Cited by 61
Humoral autoimmunity in multiple sclerosis
Meinl, E., Derfuss, T. J., Krumbholz, M., Pröbstel, A., & Hohlfeld, R. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.009 · Cited by 61
Experimental Models of Multiple Sclerosis
Lavi, E., & Constantinescu, C. S. (2005) · Springer eBooks · doi:10.1007/b135502 · Cited by 61
Broux, B., Hellings, N., Venken, K., Rummens, J., Hensen, K., Wijmeersch, B. V., & Stinissen, P. (2010) · Genes and Immunity · doi:10.1038/gene.2009.106 · Cited by 53
Owens, G. P., Burgoon, M. P., Anthony, J., Kleinschmidt-DeMasters, B. K., & Gilden, D. H. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4967 · Cited by 51
Bullard, D. C., Hu, X., Adams, J. E., Schoeb, T. R., & Barnum, S. R. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061016 · Cited by 50
Mitoxantrone and cytotoxic drugs' mechanisms of action
Vollmer, T. R., Stewart, T., & Baxter, N. N. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c97f5a · Cited by 48
Effect of cyclosporin A, silica quartz dust, and protease inhibitors on virus-induced demyelination
Rodriguez, M., & Quddus, J. (1986) · Journal of Neuroimmunology · doi:10.1016/0165-5728(86)90062-7 · Cited by 47
Tsunoda, I., Kuang, L., & Fujinami, R. S. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12834-12844.2002 · Cited by 46
Bielekova, B., Richert, N. D., Howard, T., Packer, A. N., Blevins, G., Ohayon, J. M., McFarland, H. F., Stürzebecher, C.-S., & Martinꝉ, R. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509345903 · Cited by 45
Protective and Detrimental Roles for Regulatory T Cells in a Viral Model for Multiple Sclerosis
Martinez, N. E., Karlsson, F. J., Sato, F., Kawai, E., Omura, S., Minagar, A., Grisham, M. B., & Tsunoda, I. (2014) · Brain Pathology · doi:10.1111/bpa.12119 · Cited by 44
Animal models of multiple sclerosis
Wekerle, H., & Kurschus, F. C. (2006) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2006.11.004 · Cited by 42
Targeting Inflammatory Demyelinating Lesions to Sites of Wallerian Degeneration
Tsunoda, I., Tanaka, T., Saijoh, Y., & Fujinami, R. S. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070147 · Cited by 41
Ultrastructural changes of cuprizone encephalopathy in mice
Hemm, R. D., Carlton, W. W., & Welser, J. R. (1971) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(71)90235-3 · Cited by 35
Lipton, M. M., & Freund, J. (1952) · Experimental Biology and Medicine · doi:10.3181/00379727-81-19840 · Cited by 30
Animal models for multiple sclerosis.
Owens, T. (2006) · PubMed · Cited by 30
Tsunoda, I., Libbey, J. E., & Fujinami, R. S. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.07.026 · Cited by 22
The role of cellular immune response in Theiler's virus-induced central nervous system demyelination
Njenga, M. K., Marques, C. P., & Rodriguez, M. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.042 · Cited by 15
Multiple Sclerosis: Immunology, Pathology, and Pathophysiology
Kaufman, M. (2003) · International Journal of MS Care · doi:10.7224/1537-2073-5.1.22 · Cited by 9
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Regulatory T cells in multiple sclerosis and myasthenia gravis
Danikowski, K. M., Jayaraman, S., & Prabhakar, B. S. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0892-8 · Cited by 323
Mitochondrial Dysfunction and Multiple Sclerosis
Barcelos, I. P. D., Troxell, R. M., & Graves, J. S. (2019) · Biology · doi:10.3390/biology8020037 · Cited by 291
AMPK activation: Role in the signaling pathways of neuroinflammation and neurodegeneration
Peixoto, C. A., Oliveira, W. H. D., Araújo, S. M. D. R., & Nunes, A. K. S. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.013 · Cited by 196
Bile acid signaling in neurodegenerative and neurological disorders
Grant, S. M., & DeMorrow, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175982 · Cited by 185
The Cuprizone Model: Dos and Do Nots
Zhan, J., Mann, T., Joost, S., Behrangi, N., Frank, M., & Kipp, M. (2020) · Cells · doi:10.3390/cells9040843 · Cited by 208
“A comparison of histopathological characteristics between different MS animal models is given in [6,74,75].”
Background
Metadata
- Authors
- Procaccini, C., De Rosa, V., Pucino, V., Formisano, L., & Matarese, G.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 759
- Pages
- 182-191
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2000631468
- Cited by
- 366
- References
- 152
- FWCI
- 15.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.